169 related articles for article (PubMed ID: 22764364)
1. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Tiihonen J; Krupitsky E; Verbitskaya E; Blokhina E; Mamontova O; Föhr J; Tuomola P; Kuoppasalmi K; Kiviniemi V; Zwartau E
Am J Psychiatry; 2012 May; 169(5):531-6. PubMed ID: 22764364
[TBL] [Abstract][Full Text] [Related]
2. [Naltrexone implant treatment of polydrug dependence].
Krupitskiĭ EM; Blokhina EA; Verbitskaia EV; Mamontova OV; Zvartau EE; Tiikhonen Ia
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5 Pt 2):39-45. PubMed ID: 24988974
[TBL] [Abstract][Full Text] [Related]
3. Improving clinical outcomes in treating heroin dependence: randomized, controlled trial of oral or implant naltrexone.
Hulse GK; Morris N; Arnold-Reed D; Tait RJ
Arch Gen Psychiatry; 2009 Oct; 66(10):1108-15. PubMed ID: 19805701
[TBL] [Abstract][Full Text] [Related]
4. Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial.
Jayaram-Lindström N; Hammarberg A; Beck O; Franck J
Am J Psychiatry; 2008 Nov; 165(11):1442-8. PubMed ID: 18765480
[TBL] [Abstract][Full Text] [Related]
5. Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.
Schottenfeld RS; Chawarski MC; Mazlan M
Lancet; 2008 Jun; 371(9631):2192-200. PubMed ID: 18586174
[TBL] [Abstract][Full Text] [Related]
6. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
[TBL] [Abstract][Full Text] [Related]
7. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants.
Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson R; O'Neil P
Addict Biol; 2004 Mar; 9(1):59-65. PubMed ID: 15203440
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone.
Hulse GK; Ngo HT; Tait RJ
Biol Psychiatry; 2010 Aug; 68(3):296-302. PubMed ID: 20537615
[TBL] [Abstract][Full Text] [Related]
9. A retrospective assessment of the use of naltrexone implants for the treatment of problematic amphetamine use.
Kelty E; Thomson K; Carlstein S; Sinclair R; Hulse G
Am J Addict; 2013 Jan; 22(1):1-6. PubMed ID: 23398219
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
[TBL] [Abstract][Full Text] [Related]
11. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson RC
Addict Biol; 2004 Mar; 9(1):67-72. PubMed ID: 15203441
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone for heroin dependence treatment in St. Petersburg, Russia.
Krupitsky EM; Zvartau EE; Masalov DV; Tsoi MV; Burakov AM; Egorova VY; Didenko TY; Romanova TN; Ivanova EB; Bespalov AY; Verbitskaya EV; Neznanov NG; Grinenko AY; O'Brien CP; Woody GE
J Subst Abuse Treat; 2004 Jun; 26(4):285-94. PubMed ID: 15182893
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.
Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Hegstad S; Gossop M; Kristensen Ø; Waal H
Br J Psychiatry; 2009 Jun; 194(6):541-6. PubMed ID: 19478295
[TBL] [Abstract][Full Text] [Related]
14. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
[TBL] [Abstract][Full Text] [Related]
15. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
[TBL] [Abstract][Full Text] [Related]
16. Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
Comer SD; Sullivan MA; Yu E; Rothenberg JL; Kleber HD; Kampman K; Dackis C; O'Brien CP
Arch Gen Psychiatry; 2006 Feb; 63(2):210-8. PubMed ID: 16461865
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone implants as treatment for heroin dependence: part I.
Byrne A; Graham G; Hallinan R; Murnion B
Addict Biol; 2005 Jun; 10(2):201; author reply 201-2. PubMed ID: 16191674
[No Abstract] [Full Text] [Related]
18. Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.
Krupitsky E; Zvartau E; Blokhina E; Verbitskaya E; Wahlgren V; Tsoy-Podosenin M; Bushara N; Burakov A; Masalov D; Romanova T; Tyurina A; Palatkin V; Slavina T; Pecoraro A; Woody GE
Arch Gen Psychiatry; 2012 Sep; 69(9):973-81. PubMed ID: 22945623
[TBL] [Abstract][Full Text] [Related]
19. Mortality in heroin users 3 years after naltrexone implant or methadone maintenance treatment.
Tait RJ; Ngo HT; Hulse GK
J Subst Abuse Treat; 2008 Sep; 35(2):116-24. PubMed ID: 17931824
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
